Statement of Changes in Beneficial Ownership (4)

FORM 4

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden
hours per response...

0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Foster Jon M	2. Issuer Name and Ticker or Trading Symbol HCA Healthcare, Inc. [ HCA ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) Group President
(Last)          (First)          (Middle) ONE PARK PLAZA	3. Date of Earliest Transaction (MM/DD/YYYY) 11/9/2021
(Street) NASHVILLE, TN 37203 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	5/12/2021		G	V	4919	D	$0.00	4919	D
Common Stock	5/12/2021		G	V	4919	A	$0.00	48958	I	By JMF Trust (Spouse and Robert Nagel, Co-Trustees)
Common Stock	5/12/2021		G	V	4919	D	$0.00	0	D
Common Stock	5/12/2021		G	V	4919	A	$0.00	4919	I	By Spouse
Common Stock	5/13/2021		G	V	4919	D	$0.00	0	I	By Spouse
Common Stock	5/13/2021		G	V	4919	A	$0.00	48958	I	By LCF Trust (Reporting Person, Trustee)
Common Stock	11/9/2021		M		33375	A	$47.97	33375	D
Common Stock	11/9/2021		F		17081	D	$246.14	16294	D
Common Stock	11/11/2021		S		9000	D	$241.1695 (1)	7294	D
Common Stock	11/11/2021		S		7000	D	$242.1992 (2)	294	D
Common Stock	11/11/2021		S		294	D	$242.7866 (3)	0	D
Common Stock								19985	I	By JMF Family Trust (Spouse, Trustee)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Appreciation Right	$47.97	11/9/2021		M			1500	(4)	2/5/2024	Common Stock	1500	$0.00	0	D
Stock Appreciation Right	$47.97	11/9/2021		M			31875	(5)	2/5/2024	Common Stock	31875	$0.00	0	D

Explanation of Responses:
(1)	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.73 to $241.72, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(2)	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $241.74 to $242.68, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(3)	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.75 to $242.82, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(4)	The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015.
(5)	The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Foster Jon M ONE PARK PLAZA NASHVILLE, TN 37203			Group President

Signatures
/s/ Natalie Harrison Cline, Attorney-in-Fact		11/12/2021
**Signature of Reporting Person		Date